Considering a pharmacological clinical angle, Relafen 750, identified as naproxen, presents a intriguing picture . Its mechanism of effect largely involves inhibiting cyclooxygenase catalysts , https://mediajx.com/story28435123/relafen-750-a-biochemical-pharmacy-perspective